US$ 20.70
glp-1 success IBX members face drug costs after insurance change GLP-1s and the Unintended Consequences
Description
R.CareyL

Danne T, Nimri R, Battelino T, et al

S.RheaE

Enter GLP-1 receptor agonists, a remarkable but expensive class of drugs that work by suppressing appetite, and, some researchers think, suppressing inflammation

Run the annual math
